Abstract
The base analog 8-azaguanine (8-azaG; guanazolo; 5-amino-7-hydroxy-l H-v-triazolo(d)pyrimidine) holds a special place in the field of cancer chemotherapy, since it was the first purine analog to display marked earcinostatic effects against murine malignancies. This base analog, which contains a nitrogen atom in place of the carbon in position 8 of the purine ring, has not proved useful for the treatment of human cancer. However, 8-azaG has provided a valuable tool for the molecular biologist, since the molecule is readily incorporated into the ribonucleic acids and appears to exert its cytotoxic action at that level.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Adye, J. C., Gots,J.S.: further studies on genetically altered purine nucleotide pyrophosphorylases of salmonella. Biochim. Biophys. Acta (amst.) 118, 344–350 (1966).
Agarwal,K.C., Chu,S.H., Ross,A.F., Gorske,A.F., Parks,R.E., Jr.: antitumor action of 6-selenoguanine and 6-selenoguanosine. Pharmacologist 13, 105 (1971).
Agarwal, K.C., Parks, R.E., Jr.: unpublished observation (1971).
Agarwal,R.P., Scholar,E.M., Agrawal,K.C., Parks, R.E., Jr.: identification and isolation on a large scale of guanylate kinase from human erythrocytes (effects of monophosphate nucleotides of purine analogs). Biochem. Pharmacol. 20, 1341–1354 (1970).
Anderson,E. P., Law,L.W.: biochemistry of cancer. Ann. Rev. Biochem. 29, 577–608 (1960).
Ariens, E. J., Van Rossum, J. M., Simonis, A. M.: theoretical basis of molecular pharmacology; interactions of one or two compounds with one receptor system. Arzneimittel-forsch. 6, 282–293 (1956).
Bennett,L.L., Jr., Skipper,H.E., Mitchell, J.H., Sugittra,K.: studies on the distribution of radioactive 8-azaguanine (guanazolo) in mice with eo 771 tumors. Cancer res. 10, 644–646 (1950).
Brookman, R.W., Anderson,E.P.: Biochemistry of cancer (metabolic aspects). Ann. Rev. Biochem. 32, 463–512 (1963).
Brookman, R. W., Bennett, L. L., Jr., Simpson, M. S., Wilson, A. R., Thomson, J. R., Skipper, H.E.: A mechanism of resistance to 8-azaguanine. II. Studies with experimental neoplasms. Cancer Res. 19, 856–869 (1959b).
Brookman,R.W., Sparks,M.C., Hutchison,D. J., Skipper,H.E.: A mechanism of resistance to 8-azaguanine. I. Microbiological studies on the metabolism of purines and 8-azapurines. Cancer Res. 19, 177–188 (1959a).
Brookman,R.W., Sparks,M.C., Simpson,M.S.: A comparison of the metabolism of purines and purine analogs by susceptible and drug-resistant bacterial and neoplastic cells. Biochim. biophys. Acta (Amst.) 26, 671–672 (1957).
Brown,G.B., Roll,P.M., Plentl,A.A., Cavalieri,L.P.: The utilization of adenine for nucleic acid synthesis and as a precursor of guanine. J. biol. Chem. 172, 469 (1948).
Carlo, P. E., Mandel,H.G.: The effect of 4-amino-5-imidazole carboxamide on the toxicity of 8-azaguanine. Cancer Res. 14, 459–462 (1954).
Cha,S., Parks,R.E., Jr.: Succinic thiokinase. I. Purification of the enzyme from pig heart. J. biol. Chem. 239, 1961–1967 (1964).
Chantrenne,H., Devreux,S.: Action de la 8-azaguanine sur la synthèse des protéines et des acides nucléiques chez Bacillus cereus. Biochim. biophys. Acta (Amst.) 39, 486–499 (1960).
Cohen,L.H., Parks,R.E., Jr.: Inhibition and activation of adenylosuccinic synthetase by 8-azaguanosine triphosphate. Canad. J. Biochem. 41, 1495–1501 (1963).
Creaser,E.H.: The assimilation of amino acids by bacteria. 22. The effect of 8-azaguanine upon enzyme formation in Staphylococcus aureus. Biochem. J. 64, 539 (1956).
Darlix, J.L., Fromageot,P., Reich, E.: Analysis of transcription in vitro using purine nucleotide analogs. Biochemistry 10, 1525–1531 (1971).
Elion,G.B., Bttrgi,E., Hitchings,G.H.: Studies on condensed pyrimidine systems. IX. The synthesis of some 6-substituted purines. J. Amer. chem. Soc. 74, 411–414 (1952).
Elion,G.B., Hitchings,G.H.: The synthesis of 6-thioguanine. J. Amer. chem. Soc. 77, 1676 (1955).
Emmelot,P.: The molecular basis of cancer chemotherapy. In: Ariens,E.J. (Ed.): Molecular pharmacology, Vol. 2. New York: Academic Press. 1965.
Feigelson,P., Davidson, J. D.: The inhibition of adenosine deaminase by 8-azaguanine in vitro. J. biol. Chem. 223, 65–73 (1956).
Friedkin,M.: Enzymatic synthesis of azaguanine riboside and azaguanine deoxyriboside. J. biol. Chem. 209, 295–301 (1954).
Gellhorn,A.: Laboratory and clinical studies on 8-azaguanine. Cancer 6, 1030–1033 (1953).
Gellhorn,A., Kream, J., Hirschberg,E.: Metabolism of 8-azaguanine in rabbits. Fed. Proc. 10, 297–298 (1951).
Goldin,A., Greenspan,E.M., Goldberg,B., Sohoenbach,E.B.: Studies on the mechanism of action of chemotherapeutic agents in cancer. IV. Relationship of guanine and guanylic acid to the action of guanazolo on lymphoid tumors in mice and rats. J. nat. Cancer Inst. 11, 319–338 (1950).
Grünberger,D., Holy, A., Šorm,F.: Synthesis and coding properties of 8-azaguanosine containing triribonucleoside diphosphates. Biochim. biophys. Acta (Amst.) 161, 147–155 (1968).
Grünberger,D., Meissner,L., Holy, A., Šorm,F.: The coding properties of polymers and trinucleoside diphosphates containing 8-azaguanosine. Coll. Czech. Chem. Commun. 32, 2625–2633 (1967).
Grünberger,D., O’Neal, C., Nirenberg,M.: Stimulation of amino acid incorporation into protein by polyuridylic-8-azaguanylic acid. Biochim. biophys. Acta (Amst.) 119, 581–585 (1966).
Hall,T.C., Krant,M. J., Lloyd, J.B., Patterson, W.B., Ishebara, A., Potee,K.G., Lovina, T.O., Mullen, J. M.: Treatment of localized inoperable neoplasms with intra-arterial infusions of 8-azaguanine. Cancer 15, 1156–1164 (1962).
Handschtjmacher,R.E., Welch, A. D.: Agents which influence nucleic acid metabolism. In: Cbargaff,E., Davidson, J.N. (Eds.): The nucleic acids, Vol. 3, pp. 453–526. New York: Academic Press 1960.
Heinrich,M.R., Dewey,V.C., Parks,R.E., Jr., Kidder,G.W.: The incorporation of 8- azaguanine into the nucleic acid of Tetrahymena geleii. J. biol. Chem. 197, 199–204 (1952).
HirschberGJE., Kream, J., Gellhorn, A.: Enzymatic deamination of 8-azaguanine in normal and neoplastic tissues. Cancer Res. 12, 524–528 (1952).
Hirschberg,E., Murray,M.R., Peterson,E.R., Kream,J., ScJhafranek,R., Pool,J.L.: Enzymatic deamination of 8-azaguanine in normal human brain and in glioblastoma multiforme. Cancer Res. 13, 153–157 (1953).
Kahan,F.M., Httrwitz, J.: The role of deoxyribonucleic acid in ribonucleic acid synthesis. IV. The incorporation of pyrimidine and purine analogues into ribonucleic acid. J. biol. Chem. 237, 3778–3785 (1962).
Kalle,G.P., Gots,J.S.: Alterations in purine nucleotide pyrophosphorylases and resistance to purine analogues. Biochim. biophys. Acta (Amst.) 53, 166–173 (1961).
Karnofsky, D. A., Clarkson, B. D.: Cellular effects of anticancer drugs. Ann. Rev. Pharmacol. 3, 357–428 (1963).
Karon,M., Weissman,S., Meyer,C., Henry,P.: Studies of DNA, RNA, and protein synthesis in cultured human cells exposed to 8-azaguanine. Cancer Res. 25, 185–192 (1965).
Kidder, G.W., Dewey, V.C.: The biological activity of substituted purines. J. biol. Chem. 179, 181–187 (1949).
Kidder,G.W., Dewey,V.C., Parks,R.E., Jr.: Effect of lowered essential metabolites on 8-azaguanine inhibition. J. biol. Chem. 197, 193–198 (1952).
Kidder,G.W., Dewey,V.C., Parks,R.E., Jr., Woodside,G.L.: Purine metabolism in Tetrahymena and its relation to malignant cells in mice. Science 109, 511–514 (1949).
Kidder,G.W., Dewey,V.C., Parks, R.E., Jr., Woodside,G.L.: Further evidence on the mode of action of 8-azaguanine (guanazolo) in tumor inhibition. Cancer Res. 11, 204–211 (1951).
Kondo,T., Marityama,T.: The influence of 8-azaguanine on tumors and its enhancement. Gann 42, 503–506 (1955).
Krishnan, P. S., Sitaramayya, A., Kumar, K. S.: Differential induction of cytoplasmic guanine deaminase isozymes under guanine stress in rat liver and brain. Biochem. biophys. Res. Commun. 40, 1002–1007 (1970).
Kvam,D.C., Parks,R.E., Jr.: Inhibition of hepatic-induced enzyme formation by 8-aza- guanine. J. biol. Chem. 235, 2893–2896 (1960).
Kwan,S.W., Webb,T.E.: A study of the mechanism of polyribosome breakdown induced in regenerating liver by 8-azaguanine. J. biol. Chem. 242, 5542–5548 (1967).
Kwan,S.W., Webb,T.E.: Differential sensitivity of the protein-synthesizing system of rat liver to 8-azaguanine. Life Sci. 9, 975–983 (1970).
Lasnitzki,I., Mathews, R.E.F., Smith, J. D.: Incorporation of 8-azaguanine into nucleic acids. Nature (Lond.) 173, 346 (1954).
Levin, D.H.: The polymerization of 8-azaguanosine 5’-diphosphate by polynucleotide phos- phorylase. Biochim. biophys. Acta (Amst.) 01, 75–81 (1962).
Levin, D.H.: The incorporation of 8-azaguanine into soluble ribonucleic acid of Bacillus cereus. J. biol. Chem. 238, 1098–1104 (1963).
Levin, D.H.: Evidence for an active messenger ribonucleic acid containing 8-azaguanine. Biochemistry 5, 1618–1624 (1965a).
Levin, D. H.: Amino acid acceptor and transfer functions of sRNA containing 8-azaguanine. Biochem. biophys. Res. Commun. 19, 654–660 (1965b).
Mandel,H.G.: Some aspects of the metabolism of 8-azaguanine. In: Rhoads,C.P. (Ed.): Antimetabolites and cancer, pp. 199–218. Washington, D.C.: Am. Ass. Advance. Sci. 1955.
Mandel,H.G.: The effect of 8-azaguanine on utilization of methionine by Bacillus cereus. Arch. Biochem. Biophys. 76, 230–232 (1958).
Mandel,H.G.: The physiological disposition of some anticancer agents. Pharmacol. Rev. 11, 743–838 (1959).
Mandel,H.G.: Further studies on the modification of nucleic acid synthesis of B. cereus by 8-azaguanine. J. Pharmacol, exp. Ther. 133, 141–150 (1961).
Mandel,H.G., Alpen,E.L., Winters, W.D., Smith, P. K.: The urinary metabolites of 8-aza- guanine in the mouse and the monkey. J. biol. Chem. 193, 63–71 (1951).
Mandel,H.G., Altman,R.L.: The depression of the incorporation of sulfur amino acids into Bacillus cereus by 8-azaguanine. J. biol. Chem. 235, 2029–2035 (1960).
Mandel,H.G., Markham,R.: The effect of 8-azaguanine on the biosynthesis of ribonucleic acid in Bacillus cereus. Biochem. J. 69, 297–306 (1958).
Mathews, R.E.F.: Biosynthetic incorporation of metabolite analogues. Pharmacol. Rev. 10, 359–406 (1958).
Mieoh,R.P., Parks,R.E., Jr.: Adenosine triphosphate: guanosine monophosphate phosphotransferase (partial purification and substrate specificity). J. biol. Chem. 240, 351–357 (1965).
Miech,R.P., York,R., Parks,R.E., Jr.: Adenosine triphosphate-guanosine 5’-phosphate phosphotransferase. II. Inhibition by 6-thioguanosine 5’-phosphate of the enzyme isolated from hog brain and sarcoma 180 ascites cells. Molec. Pharmacol. 5, 30–37 (1969).
Montgomery,J.A.: On the chemotherapy of cancer. Progr. Drug Res. 8, 431–507 (1965).
Mourad,N., Parks,R.E., Jr.: Erythrocytic nucleoside diphosphokinase. II. Isolation and kinetics. J. biol. Chem. 241, 271–278 (1966).
O’Brien, B.R. A.: 8-Azaguanine inhibition of haemoglobin synthesis in de-embryonated chick blastoderm. Nature (Lond.) 184, 376–377 (1959).
Parks, R.E., Jr.: Antimetabolite studies in Tetrahymena and tumors. IN: Rhoads,C.P. (Ed.): Antimetabolites and cancer, pp. 175–197. Washington, D.C.: Am. Assoc. Advance. Sci. 1955.
Parks,R.E., Jr.: Studies with 8-azaguanine and other purine antimetabolites. II Farmaco, 17, 627–646 (1962).
Parks, R.E., Jr.: Cancer chemotherapy with purine antimetabolites. In: Buses:,H. (Ed.): Biochemical frontiers in medicine, pp. 245–273.: Little, Brown and Company 1963.
Roblin,R.O., Jr., Lampen, J.O., English,J.P., Cole, Q.P., Vaughan,J.R.: Studies in chemotherapy. VIII. Methionine and purine antagonists and their relation to the sulfonamides. J. Am. chem. Soc. 67, 290–294 (1945).
Roodyn,D.B., Mandel,H.G.: The differential effect of 8-azaguanine on cell wall and protoplasmic protein synthesis in Bacillus cereus. J. biol. Chem. 235, 2036–2044 (1960).
Ross,A.F., Parks,R.E., Jr.: Unpublished observation (1971).
Rotjsh,A., Norris,E.R.: Deamination of 8-azaguanine by guanase. Arch. Biochem. Biophys. 29, 124–129 (1950).
Roy,J.K., Kvam,D.C., Dahl,J.L., Parks,R.E., Jr.: Effect of triphosphate nucleosides of 8-azaguanine, 6-thioguanine, and 6-mercaptopurine on amino acid incorporation in vitro into microsomal protein. J. biol. Chem. 236, 1158–1162 (1961).
Roy-Burman,P.: Analogues of nucleic acid components. In: Rentohnick,P. (Ed.): Recent results in cancer research, pp. 28–32. New York: Springer 1970.
ScJhacter,B., Law,L.W.: Azaguanine-deaminase activity of several lymphocytic leukemias of mice. J. nat. Cancer Inst. 18, 77–81 (1957).
Skipper, H.E., Bennett, L.L., Jr.: Biochemistry of cancer. Ann. Rev. Biochemistry 27,157– 166 (1958).
Smith, J. D., Mathews, R.E.F.: The metabolism of 8-azapurines. Biochem. J. 66, 323–333 (1957).
Stock, J. A.: Antimetabolites. IN: Schnitzer,R. J., Hawking,P. (Eds.): Experimental chemotherapy, Vol. 4, pp. 80–196. New York: Academic Press 1966.
Sugiura,K., Hitchings,G.H., Cavalieri,L.F., Stock, C.C.: The effect of 8-azaguanine on the growth of carcinoma, sarcoma, osteogenic sarcoma, lymphosarcoma and melanoma in animals. Cancer Res. 10, 178–185 (1950).
Ultmann,J.E., Feigelson, P.: The effects of 8-azaguanine and 6-mercaptopurine on purine catabolism in the rat. Cancer Res. 18, 1319–1323 (1958).
Ward,D.C., Fuller, W., Reich,E.: Stereochemical analysis of the specificity of pancreatic RNAase with polyformycin as substrate: differentiation of the transphosphorylation and hydrolysis reactions. Proc. nat. Acad. Sciences 62, 581–588 (1969).
Way,J.L., Dahl,J.L., Parks,R.E., Jr.: Polyphosphate nucleosides of purine analogues. J. biol. Chem. 234, 1241–1243 (1959).
Way,J.L., Parks, R.E., Jr.: Enzymatic synthesis of 5’-phosphate nucleotides of purine analogues. J. biol. Chem. 231, 467–480 (1958).
Webb, T. E.: Polyribosome breakdown in rat liver following administration of 8-azaguanine. Biochim. biophys. Acta (Amst.) 138, 307–315 (1967).
Zimmerman, E.F.: Azaguanine inhibition of protein synthesis. III. Site of action in HeLa cells. Biochim. biophys. Acta (Amst.) 157, 378–391 (1968).
Zimmerman,E.F., Greenberg,S.A.: Inhibition of protein synthesis by 8-azaguanine. I. Effects on polyribosomes in HeLa cells. Molec. Pharmacol. 1, 113–125 (1965).
Zimmerman,E.F., Holler,B.W., Pearson,G.D.: Azaguanine inhibition of protein synthesis. II. Effects of poly (U) in Bacillus cereus. Biochim. Biophys. Acta (Amst.) 134, 402–410 (1967).
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1975 Springer-Verlag Berlin · Heidelberg
About this chapter
Cite this chapter
Parks, R.E., Agarwal, K.C. (1975). 8-Azaguanine. In: Sartorelli, A.C., Johns, D.G. (eds) Antineoplastic and Immunosuppressive Agents. Handbuch der experimentellen Pharmakologie / Handbook of Experimental Pharmacology, vol 38 / 2. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-65806-8_22
Download citation
DOI: https://doi.org/10.1007/978-3-642-65806-8_22
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-65808-2
Online ISBN: 978-3-642-65806-8
eBook Packages: Springer Book Archive